UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Pulsed-Field Gel Electrophoresis Analysis of Bordetella pertussis Isolates Circulating in Europe from 1998 to 2009

Journal of Clinical Microbiology, 2013-02, Vol.51 (2), p.422-428

2013

Volltextzugriff (PDF)

A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine

The New England journal of medicine, 1996-02, Vol.334 (6), p.349-356

1996

Volltextzugriff (PDF)

SNP-based typing: a useful tool to study Bordetella pertussis populations

PloS one, 2011-05, Vol.6 (5), p.e20340-e20340

2011

Volltextzugriff (PDF)

Shifts of Bordetella pertussis Variants in Sweden from 1970 to 2003, during Three Periods Marked by Different Vaccination Programs

Journal of Clinical Microbiology, 2005-06, Vol.43 (6), p.2856-2865

2005

Volltextzugriff (PDF)

Antibody Response Patterns to Bordetella pertussis Antigens in Vaccinated (Primed) and Unvaccinated (Unprimed) Young Children with Pertussis

Clinical and Vaccine Immunology, 2010-05, Vol.17 (5), p.741-747

2010

Volltextzugriff (PDF)

How to Make Sense of Pertussis Immunogenicity Data

Clinical infectious diseases, 2001-12, Vol.33 (Supplement-4), p.S288-S291

2001

Volltextzugriff (PDF)

Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2009-12, Vol.117 (12), p.912-922

2009

Volltextzugriff (PDF)

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

Vaccine, 1998-12, Vol.16 (20), p.1907-1916

1998

Volltextzugriff (PDF)

Appearance of Fim3 and ptxP3 - Bordetella pertussis strains, in two regions of Sweden with different vaccination programs

Vaccine, 2011-04, Vol.29 (18), p.3438-3442

2011

Volltextzugriff (PDF)

Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2009-11, Vol.117 (11), p.797-807

2009

Volltextzugriff (PDF)

Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis

BMC immunology, 2015-07, Vol.16 (1), p.40-40, Article 40

2015

Volltextzugriff (PDF)

Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience

Expert review of vaccines, 2009-10, Vol.8 (10), p.1303-1307

2009

Volltextzugriff (PDF)

Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose

Vaccine, 2005-11, Vol.23 (46-47), p.5359-5364

2005

Volltextzugriff (PDF)

Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis

Vaccine, 2003-09, Vol.21 (25-26), p.3542-3549

2003

Volltextzugriff (PDF)

Acellular pertussis vaccines and the role of pertactin and fimbriae

Expert review of vaccines, 2007-02, Vol.6 (1), p.47-56

2007

Volltextzugriff (PDF)

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine

The Lancet (British edition), 1997-11, Vol.350 (9091), p.1569-1577

1997

Volltextzugriff (PDF)

Do we need a booster of Hib vaccine after primary vaccination? A study on anti‐Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-11, Vol.118 (11), p.878-887

2010

Volltextzugriff (PDF)

Is adolescent pertussis vaccination preferable to natural booster infections?

Expert review of clinical pharmacology, 2011-11, Vol.4 (6), p.705-711

2011

Volltextzugriff (PDF)

Microbiological and Serological Diagnosis of Pertussis

Clinical infectious diseases, 1999-06, Vol.28 (Supplement-2), p.S99-S106

HALLANDER, H. O

1999

Volltextzugriff (PDF)

Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2009-09, Vol.117 (9), p.660-671

2009

Volltextzugriff (PDF)

Performance of Bordetella pertussis IS481 real-time PCR in a vaccine trial setting

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2007-12, Vol.115 (12), p.1370-1375

2007

Volltextzugriff (PDF)

Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies

Microbes and infection, 2005-06, Vol.7 (7), p.976-982

2005

Volltextzugriff (PDF)

SHIFTS OF ROTAVIRUS G AND P TYPES IN NICARAGUA‐2001–2003

The Pediatric infectious disease journal, 2006-11, Vol.25 (11), p.1078-1080

2006

Volltextzugriff (PDF)

Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2007-06, Vol.115 (6), p.736-742

2007

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(76)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(53)
Humans
(47)
Microbiology
(34)
Infectious Diseases
(33)
Biological And Medical Sciences
(31)
Immunology
(23)
Medical Sciences
(23)
Bordetella Pertussis
(17)
Vaccination
(17)
Child, Preschool
(16)
Fundamental And Applied Biological Sciences. Psychology
(16)
Bacteriology
(15)
Infant
(15)
Antibodies, Bacterial - Blood
(14)
Whooping Cough - Prevention & Control
(14)
Bacterial Diseases
(13)
Child
(13)
Female
(13)
Pertussis Vaccine - Immunology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pulsed-Field Gel Electrophoresis Analysis of Bordetella pertussis Isolates Circulating in Europe from 1998 to 2009

A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine

SNP-based typing: a useful tool to study Bordetella pertussis populations

Shifts of Bordetella pertussis Variants in Sweden from 1970 to 2003, during Three Periods Marked by Different Vaccination Programs

Antibody Response Patterns to Bordetella pertussis Antigens in Vaccinated (Primed) and Unvaccinated (Unprimed) Young Children with Pertussis

How to Make Sense of Pertussis Immunogenicity Data

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination

Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

Appearance of Fim3 and ptxP3 - Bordetella pertussis strains, in two regions of Sweden with different vaccination programs

Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children

Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis

Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience

Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose

Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis

Acellular pertussis vaccines and the role of pertactin and fimbriae

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine

Do we need a booster of Hib vaccine after primary vaccination? A study on anti‐Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease

Is adolescent pertussis vaccination preferable to natural booster infections?

Microbiological and Serological Diagnosis of Pertussis

Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection

Performance of Bordetella pertussis IS481 real-time PCR in a vaccine trial setting

Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies

SHIFTS OF ROTAVIRUS G AND P TYPES IN NICARAGUA‐2001–2003

Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype

Suchergebnisse filtern